Cargando…

Multiple Roles of Angiopoietin-Like 4 in Osteolytic Disease

Hypoxia and the hypoxia-inducible factor (HIF) transcription factor drive pathological bone loss in conditions including rheumatoid arthritis (RA), osteoarthritis, osteoporosis, primary bone tumours, and bone metastatic cancer. There is therefore considerable interest in determining the function(s)...

Descripción completa

Detalles Bibliográficos
Autor principal:	Knowles, Helen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394121/ https://www.ncbi.nlm.nih.gov/pubmed/28458654 http://dx.doi.org/10.3389/fendo.2017.00080

Ejemplares similares

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
por: Coniglio, Salvatore J.
Publicado: (2018)

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases
por: Ersek, Adel, et al.
Publicado: (2012)

Angiopoietin-Like Proteins: A Comprehensive Look
por: Santulli, Gaetano
Publicado: (2014)

Increased Level of Angiopoietin Like Proteins 4 and 8 in People With Sleep Apnea
por: Al-Terki, Abdulmohsen, et al.
Publicado: (2018)

Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4
por: Knowles, Helen J., et al.
Publicado: (2010)

Maternal Serum Angiopoietin-Like 3 Levels in Healthy and Mild Preeclamptic Pregnant Women
por: Garces, María Fernanda, et al.
Publicado: (2021)

Angiopoietin-Like 4 Is Over-Expressed in Rheumatoid Arthritis Patients: Association with Pathological Bone Resorption
por: Swales, Catherine, et al.
Publicado: (2014)

Multiple Osteolytic Lesions
por: Vinayachandran, Divya, et al.
Publicado: (2013)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017)

Angiopoietin-Like Protein 8/Leptin Crosstalk Influences Cardiac Mass in Youths With Cardiometabolic Risk: The BCAMS Study
por: Wang, Dongmei, et al.
Publicado: (2022)

Angiopoietin-like-4 and minimal change disease
por: Cara-Fuentes, Gabriel, et al.
Publicado: (2017)

Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis
por: Zhang, T., et al.
Publicado: (2018)

Association of Serum Angiopoietin-Like Protein 8 With Albuminuria in Type 2 Diabetic Patients: Results From the GDMD Study in China
por: Yang, Liuxue, et al.
Publicado: (2018)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease
por: Chugh, Sumant S., et al.
Publicado: (2014)

A review of the multifunctionality of angiopoietin-like 4 in eye disease
por: Yang, Xinyue, et al.
Publicado: (2018)

The role of angiopoietin-like protein 4 in phenylephrine-induced cardiomyocyte hypertrophy
por: Sun, Yu, et al.
Publicado: (2019)

Angiopoietin-Like 4 Regulates Epidermal Differentiation
por: Pal, Mintu, et al.
Publicado: (2011)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Osteolytic lesions: Multiple myeloma or prostate cancer?
por: Devaraj, Akshitha, et al.
Publicado: (2023)

Preventing osteolytic lesions and osteomyelitis in multiple myeloma
por: Dao, Aiken, et al.
Publicado: (2022)

Distinct roles of angiopoietin-like 4 in the regulation of central and peripheral lipid metabolism?()
por: Blüher, Matthias
Publicado: (2014)

Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease
por: Erkan, Gulbanu, et al.
Publicado: (2016)

Angiopoietin-like 4 in glucocorticoid induced insulin resistance
por: Lee, Rebecca A., et al.
Publicado: (2017)

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Role of Altered Metabolic Microenvironment in Osteolytic Metastasis
por: Tiedemann, Kerstin, et al.
Publicado: (2020)

Osteolytic lesions in myelofibrosis
por: Johnson, Isla, et al.
Publicado: (2021)

Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
por: Kersten, Sander
Publicado: (2021)

Multiple osteolytic lesions in a 14-year-old boy with HIV disease
por: Murugan, S.
Publicado: (2015)

The Role of Angiopoietin-1 in Kidney Disease
por: Kim, Won
Publicado: (2008)

Multiple myeloma presenting as a massive osteolytic lesion at the clivus
por: Sousa, Domingos, et al.
Publicado: (2020)

Cooperation of Angiopoietin-2 and Angiopoietin-4 in Schlemm's Canal Maintenance
por: Kapiainen, Emmi, et al.
Publicado: (2022)

Multiple roles and regulatory mechanisms of the transcription factor HNF4 in the intestine
por: Vemuri, Kiranmayi, et al.
Publicado: (2023)

Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity
por: Bhatraju, Pavan K., et al.
Publicado: (2022)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
por: Gai, Dongzheng, et al.
Publicado: (2022)

Tuberculosis of the foot: An osteolytic variety
por: Dhillon, Mandeep S, et al.
Publicado: (2012)

Solitary Tibial Osteolytic Lesion
por: Pakos, Emilios E., et al.
Publicado: (2009)

Pathological fracture on osteolytic lesion
por: Traore, Ousmane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1i2nteq86cvc71k4p6a6a0egeh